Connection
Paul Prather to Guanosine 5'-O-(3-Thiotriphosphate)
This is a "connection" page, showing publications Paul Prather has written about Guanosine 5'-O-(3-Thiotriphosphate).
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.314 |
|
|
|
-
Ford BM, Franks LN, Radominska-Pandya A, Prather PL. Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development. PLoS One. 2016; 11(12):e0167240.
Score: 0.144
-
Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. J Pharmacol Exp Ther. 2005 Aug; 314(2):868-75.
Score: 0.064
-
Liu JG, Prather PL. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors. J Pharmacol Exp Ther. 2002 Sep; 302(3):1070-9.
Score: 0.053
-
Martin NA, Ruckle MB, VanHoof SL, Prather PL. Agonist, antagonist, and inverse agonist characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a selective delta-opioid receptor ligand. J Pharmacol Exp Ther. 2002 May; 301(2):661-71.
Score: 0.052